PMID: 9438209Jan 23, 1998Paper

The CCR5 deletion mutation fails to protect against multiple sclerosis

Human Immunology
B H BennettsG J Stewart

Abstract

Recent advances in the understanding and identification of chemokines and their receptors have provided evidence for their consideration as candidate loci with respect to genetic susceptibility/resistance to MS. Increased levels of the chemokine, macrophage inflammatory protein (MIP)-1 alpha, have been demonstrated in the cerebrospinal fluid of both patients with MS and mice with EAE, and anti-MIP-1 alpha antibodies have been shown to prevent EAE. Recently, a common deletion mutation in the gene for the major receptor for MIP-1 alpha, chemokine receptor 5 (CCR5) has been described. Homozygotes for the mutation fail to express this receptor. Moreover, homozygotes are highly protected against HIV infection this has potential implications for the cell entry of infectious agents in other multifactorial disease where a viral component may be involved. In view of these aspects, a group of 120 unrelated Australian relapsing remitting MS and 168 unrelated control subjects were screened for the CCR5 delta 32 mutation. There was no significant difference in the allele frequency of CCR5 delta 32 gene between the MS patients (0.1125) and the control population (0.0921). The presence of two CCR5 delta 32 homozygotes in the MS patients indic...Continue Reading

References

Feb 1, 1988·Brain : a Journal of Neurology·S R HammondM G McCall
Sep 1, 1983·American Journal of Physical Anthropology·W C KnowlerR C Williams
Sep 1, 1983·American Journal of Physical Anthropology·G M Petersen, J I Rotter
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
May 1, 1995·Journal of Neuroimmunology·R GodiskaP W Gray
Aug 1, 1993·Journal of Neuroimmunology·E Martínez-NavesC López-Larrea
Aug 1, 1996·Nature Genetics·J I Bell, G M Lathrop
Aug 1, 1996·Nature Genetics·G C EbersN Risch
Apr 1, 1996·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·S M TeutschG J Stewart
Jun 1, 1996·Cytokine & Growth Factor Reviews·P M Murphy
Feb 13, 1997·Nature·B J WillettJ A Hoxie
Feb 28, 1997·Science·J Cohen
Apr 1, 1997·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·G J StewartB H Bennetts

❮ Previous
Next ❯

Citations

May 30, 2009·Cellular and Molecular Neurobiology·Majid ShahbaziMahdi Zamani
Dec 20, 2012·Inflammation·Khodayar GhorbanDerek Kennedy
Dec 4, 2003·Journal of Neuroimmunology·Ryuji MiyagishiKunio Tashiro
May 17, 2005·Pharmacology & Therapeutics·Sofia Ribeiro, Richard Horuk
Apr 19, 2002·Biochemical Pharmacology·Maureen N AjueborMauro Perretti
Jul 6, 2002·Journal of Neuroimmunology·Masaru MatsuiRichard M Ransohoff
Jan 8, 2000·Journal of Neuroimmunology·F SellebjergP Garred
Aug 12, 2003·Brain Research Bulletin·F Sellebjerg, T L Sørensen
Jan 23, 1999·Current Opinion in Immunology·S Sawcer, P N Goodfellow
Aug 8, 2001·Journal of Internal Medicine·M Baggiolini
Sep 13, 2002·Immunology and Cell Biology·Petra D Cravens, Peter E Lipsky
Sep 10, 2004·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Radhika Gade-AndavoluLawrence A Cone
Dec 22, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A Compston
Feb 28, 2002·Journal of Virology·Daniah A D ThompsonTatjana Dragic
Jul 27, 2002·Annual Review of Genomics and Human Genetics·Michael DeanStephen J O'Brien
Mar 17, 1999·The Journal of Clinical Investigation·T L SørensenR M Ransohoff
Jun 2, 2000·Clinical Chemistry and Laboratory Medicine : CCLM·A Compston
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·K E BalashovW W Hancock
Apr 19, 2013·Genes and Immunity·V SuppiahUNKNOWN International Hepatitis C Genetics Consortium (IHCGC)
Jul 18, 2001·The Journal of General Virology·T Dragic
Nov 18, 2003·Acta Neurologica Scandinavica·M LuomalaI Elovaara
Apr 15, 2004·Acta Neurologica Scandinavica·K PulkkinenI Elovaara
May 22, 2007·Acta Neurologica Scandinavica·F SellebjergT L Sørensen
Apr 27, 2007·Annals of the New York Academy of Sciences·Carmela Rita BalistreriGiuseppina Candore
Feb 14, 2007·Acta Neurologica Scandinavica·Adam Szczuciński, Jacek Losy
May 15, 2013·Acta Neurologica Scandinavica·M MøllerA B Oturai
Nov 4, 2000·Expert Opinion on Investigational Drugs·R M Ransohoff, K B Bacon
Dec 18, 2010·Progress in Neurobiology·Silvia SorceKarl-Heinz Krause
Aug 10, 2010·Biochimica Et Biophysica Acta·David W HolmanRichard M Ransohoff
Sep 22, 2007·Journal of Neuroimmunology·Tineke van VeenBernard M J Uitdehaag
Jul 10, 2008·Multiple Sclerosis : Clinical and Laboratory Research·C TrebstM Stangel
Mar 1, 2000·Multiple Sclerosis : Clinical and Laboratory Research·G X ZhangA M Rostami
Mar 29, 2001·Nature Immunology·C Gerard, B J Rollins
Apr 5, 2002·European Journal of Immunology·Rachael ReimanScott R Barnum

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.